Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

This study has been terminated.
(poor data collection)
Sponsor:
Collaborator:
National Health and Medical Research Council, Australia
Information provided by:
Melbourne Health
ClinicalTrials.gov Identifier:
NCT00241956
First received: October 18, 2005
Last updated: July 19, 2011
Last verified: July 2011
  Purpose

To assess whether patients with diabetes have less clinical improvement during inpatient rehabilitation than those without diabetes and whether hyperglycaemia during rehabilitation is an adverse prognostic indicator.


Condition
Cerebrovascular Accident
Diabetes
Hyperglycemia

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

Resource links provided by NLM:


Further study details as provided by Melbourne Health:

Enrollment: 20
Study Start Date: October 2005
Study Completion Date: May 2006
Primary Completion Date: May 2006 (Final data collection date for primary outcome measure)
Detailed Description:

Patients with diabetes have a higher mortality rate and more severe disability from stroke compared to those without diabetes. Those with hyperglycaemia tend to progress to a larger final stroke size. Diabetes and hyperglycaemia may affect the ability of the patient to clinically improve, independent of the degree of initial impairment. We will perform a retrospective review of medical records of stroke patients admitted to an inpatient rehabilitation unit. We will compare outcomes of changes in disability scales (FIM and Barthel) from admission to discharge, length of stay and hospital events between those with and without diabetes. Amongst those with diabetes, we will also assess whether those with higher mean blood glucose levels during their inpatient rehabilitation stay have worse outcomes.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Stroke rehab patients

Criteria

Inclusion Criteria:

  • Inpatient rehabilitation for acute stroke

Exclusion Criteria:

  • Medical records unavailable
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00241956

Locations
Australia, Victoria
The Royal Melbourne Hospital
Melbourne, Victoria, Australia, 3050
Sponsors and Collaborators
Melbourne Health
National Health and Medical Research Council, Australia
Investigators
Principal Investigator: Leo Rando, MBBS FRACP Melbourne Health
  More Information

No publications provided

Responsible Party: Dr Leo Rando, Royal Melbourne Hospital
ClinicalTrials.gov Identifier: NCT00241956     History of Changes
Other Study ID Numbers: 2004.246
Study First Received: October 18, 2005
Last Updated: July 19, 2011
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

Additional relevant MeSH terms:
Diabetes Mellitus
Hyperglycemia
Cerebral Infarction
Stroke
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on August 18, 2014